Skip to main content
. 2023 Jul 6;129(5):741–753. doi: 10.1038/s41416-023-02317-8

Fig. 2. Utilisation of radiogenomics in clinical practice for the treatment of hepatocellular carcinoma and breast cancer.

Fig. 2

a Combining imaging features of hepatocellular carcinoma with genetic modules to build models for predicting prognosis and recurrence. b Breast MR imaging radiogenomics allows for the assessment of correlations between imaging features and breast cancer molecular subtypes of luminal A, luminal B, HER2 and triple-negative cancer.